Achilles Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	2013 - 2017
Period Ending	Aug '25 Aug 13, 2025	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	Aug '19 Aug 31, 2019	Aug '18 Aug 31, 2018	2013 - 2017
Market Capitalization	1	1	3	3	8	4	Upgrade
Market Cap Growth	-52.48%	-52.48%	-8.06%	-61.03%	128.87%	4776.40%	Upgrade
Enterprise Value	-	10	11	4	9	4	Upgrade
Last Close Price	0.00	0.00	0.04	0.12	0.67	0.30	Upgrade
PS Ratio	0.62	1.35	1.88	121.46	-	-	Upgrade
PB Ratio	-0.14	-0.31	2.22	-2.28	137.04	-27.25	Upgrade
P/TBV Ratio	-	-	-	-	137.04	-	Upgrade
EV/Sales Ratio	-	9.28	6.74	144.34	-	-	Upgrade
Debt / Equity Ratio	-0.83	-0.83	2.96	-1.65	0.77	-0.69	Upgrade
Asset Turnover	0.16	0.16	0.23	0.02	-	-	Upgrade
Inventory Turnover	4.37	4.37	10.72	0.63	-	-	Upgrade
Quick Ratio	0.06	0.06	0.02	0.00	0.99	0.03	Upgrade
Current Ratio	0.20	0.20	0.05	0.02	1.01	0.03	Upgrade
Return on Assets (ROA)	-24.75%	-24.75%	-17.78%	-178.34%	-313.19%	-672.67%	Upgrade
Return on Capital (ROIC)	-70.82%	-70.82%	-38.61%	-435.51%	-1036.02%	-	Upgrade
Earnings Yield	-2109.87%	-966.46%	-259.83%	-150.29%	-4.63%	-2.36%	Upgrade
FCF Yield	-150.57%	-68.97%	-49.10%	-46.88%	-1.47%	-0.97%	Upgrade
Buyback Yield / Dilution	-595.94%	-595.94%	-240.84%	-39.48%	-63.35%	-109.03%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.